Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
About
Company Overview
Leadership
Scientific Advisory Board
Collaborations
Technology
Stimulant Abuse
How it Works
Mechanism of Action
Clinical Data
Publications
Pipeline
Overview
ADAIR
ADMIR
ADHD
Narcolepsy
Patient Resources
Newsroom
Investors
Investors
Press Releases
Events + Presentations
Company Information
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
News Alerts
Contact
Vallon Pharmaceuticals and
GRI Bio
Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
We hosted a joint webcast on December 14, 2022 – Access the Webcast Replay
Here
All Posts By
vendor
Close Menu
About
Company Overview
Leadership
Scientific Advisory Board
Collaborations
Technology
Stimulant Abuse
How it Works
Mechanism of Action
Clinical Data
Publications
Pipeline
Overview
ADAIR
ADMIR
ADHD
Narcolepsy
Patient Resources
Newsroom
Investors
Investors
Press Releases
Events + Presentations
Company Information
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
News Alerts
Contact